Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02699957 · ClinicalTrials.gov registry record
Left Atrial Appendage Occlusion Registry (LAAO Registry)
A clinical trial of Atrial Fibrillation, sponsored by American College of Cardiology.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT02699957: Recruiting study of Atrial Fibrillation, sponsored by American College of Cardiology.
NCT02699957 is a study of Atrial Fibrillation that is actively recruiting participants, run by American College of Cardiology. The registered enrollment target is 3,000 participants, roughly in line with the 2,982-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02699957, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by American College of Cardiology.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Left Atrial Appendage Occlusion Registry (LAAO Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous and epicardial based left atrial appendage occlusion procedures to reduce the risk of stroke. Patient-level data will be submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The primary aims of the LAAO Registry are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing percutaneous and epicardial based left atrial appendage procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the LAAO Registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost effectiveness research, and as a scalable data infrastructure for post market studies.
Primary Outcome
Proportion of patients experiencing any of the following events: Procedure aborted, conversion to open heart, hemorrhagic, ischemic or undetermined stroke, any effusion requiring drainage or surgery, device embolization, systemic embolism, or major bleeding event.
Conditions Studied
Interventions
- PROCEDURE Left Atrial Appendage Occlusion
Study Locations (1)
District of Columbia
- American College of Cardiology/National Cardiovascular Data Registry (NCDR) - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2015-12 |
| Est. Completion | 2026-01 |
What NCT02699957 shows while recruiting
NCT02699957 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,982-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Left Atrial Appendage Occlusion is the first listed.
NCT02699957 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02699957 about?
NCT02699957 is a clinical study titled "Left Atrial Appendage Occlusion Registry (LAAO Registry)". The Left Atrial Appendage Occlusion Registry (LAAO Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous and epicardial based left atrial appendage occlusion procedures to reduce the risk of stroke. Patient-level data will be subm...
What is the current status of trial NCT02699957?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2015-12. Estimated completion is 2026-01.
What conditions does trial NCT02699957 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT02699957?
The interventions under investigation include: Left Atrial Appendage Occlusion (PROCEDURE).
Who is sponsoring clinical trial NCT02699957?
This trial is sponsored by American College of Cardiology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02699957 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02699957's enrollment target sits among peer trials
3,000 21st of 202 higher than 180 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia